RA CAPITAL MANAGEMENT, LLC Insider Trading $LIPD LIPID SCIENCES INC/

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN).

RA CAPITAL MANAGEMENT, LLC in LIPID SCIENCES INC/

Trading Symbol: LIPD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RA CAPITAL MANAGEMENT, LLC: 10% Owner
Holdings: 3,713,962 shares
Latest Transaction: Mar 28 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC in LIPID SCIENCES INC/

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 28 2007LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerBuyP1.403004203,713,9623.7 M to 3.7 M (+0.01 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.571,6002,5123,662,6623.7 M to 3.7 M (-0.04 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.563,1004,8363,664,2623.7 M to 3.7 M (-0.08 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.5520,40031,6203,667,3623.7 M to 3.7 M (-0.55 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.549,20414,1743,687,7623.7 M to 3.7 M (-0.25 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.531001533,696,9663.7 M to 3.7 M (0.00 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.529001,3683,697,0663.7 M to 3.7 M (-0.02 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.511001513,697,9663.7 M to 3.7 M (0.00 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.5015,44223,1633,698,0663.7 M to 3.7 M (-0.42 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.479001,3233,713,5083.7 M to 3.7 M (-0.02 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.451,0501,5233,714,4083.7 M to 3.7 M (-0.03 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.441,7002,4483,715,4583.7 M to 3.7 M (-0.05 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.434005723,717,1583.7 M to 3.7 M (-0.01 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.422,0402,8973,717,5583.7 M to 3.7 M (-0.05 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.412,9004,0893,719,5983.7 M to 3.7 M (-0.08 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.371,2501,7133,722,4983.7 M to 3.7 M (-0.03 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.362,2002,9923,723,7483.7 M to 3.7 M (-0.06 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.3524,63033,2513,725,9483.8 M to 3.7 M (-0.66 %)
Dec 29 2006LIPDLIPID SCIENCES INC ...RA CAPITAL MANAGEMENT, LLC10% OwnerSellS1.4012,68417,7583,750,5783.8 M to 3.8 M (-0.34 %)

Page:   1